Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma
Phase 1/2 Completed
64 enrolled 13 charts
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Phase 3 Completed
727 enrolled 13 charts
Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute Leukemia
Phase 2 Completed
16 enrolled 9 charts
Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)
Phase 2 Completed
11 enrolled 12 charts
Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia.
Phase 1 Completed
18 enrolled 15 charts
Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma
Phase 2 Completed
6 enrolled 10 charts
Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease
Phase 1/2 Completed
38 enrolled 12 charts
Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma
Phase 2 Completed
80 enrolled 13 charts
Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia
Phase 3 Completed
600 enrolled 16 charts
HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies
Phase 2 Completed
422 enrolled 19 charts
NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma
Phase 2 Completed
23 enrolled 14 charts
Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment
Phase 1/2 Completed
29 enrolled 15 charts
Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Phase 3 Completed
256 enrolled 13 charts
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
Phase 3 Completed
324 enrolled 13 charts
Clofarabine Combinations in Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) and Myeloid Blast Phase Chronic Myeloid Leukemia (CML)
Phase 2 Completed
116 enrolled 10 charts
Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant
Phase 2 Completed
44 enrolled 15 charts
Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome
Phase 1/2 Completed
282 enrolled 13 charts
Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia
Phase 1/2 Completed
65 enrolled 12 charts
LAL1610
Phase 2 Completed
35 enrolled 11 charts
Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)
Phase 2 Completed
42 enrolled 10 charts
Clofarabine, Idarubicin, and Cytarabine Combination in Acute Myeloid Leukemia (AML) Induction
Phase 2 Completed
63 enrolled 6 charts
Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation
Phase 2 Completed
120 enrolled 8 charts
Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS)
Phase 2 Completed
81 enrolled 9 charts
Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Phase 1/2 Completed
50 enrolled 13 charts
Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen
Phase 1/2 Completed
46 enrolled 11 charts
Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL)
Phase 1/2 Completed
33 enrolled 9 charts
AML1107
Phase 2 Completed
60 enrolled 9 charts
S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Phase 2 Completed
35 enrolled 7 charts
Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm
Phase 2 Completed
50 enrolled 10 charts
Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation
Phase 2 Completed
34 enrolled 19 charts
Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS
Phase 1/2 Completed
35 enrolled 11 charts
A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia
Phase 2 Completed
39 enrolled 7 charts
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Phase 1/2 Completed
74 enrolled 17 charts
CloBu4
Phase 2 Completed
75 enrolled 7 charts
Treatment of Older Adults With Acute Lymphoblastic Leukemia
Phase 2 Completed
30 enrolled 9 charts
Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
Phase 2 Completed
122 enrolled 10 charts
Oral Clofarabine Study in Patients With Myelodysplastic Syndrome
Phase 2 Completed
65 enrolled 7 charts
S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Phase 2 Completed
36 enrolled 7 charts
Natural Killer (NK) Cell Transplantation for AML
Phase NA Completed
49 enrolled 17 charts
A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.
Phase 1/2 Completed
50 enrolled 31 charts
A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)
Phase 3 Completed
326 enrolled 26 charts
A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)
Phase 2 Completed
116 enrolled 23 charts
Clofarabine Bone Marrow Cytoreduction
Phase 2 Completed
29 enrolled 12 charts
Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies
Phase 1/2 Completed
82 enrolled 12 charts
Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS
Phase 2 Completed
30 enrolled 8 charts
Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients
Phase 1/2 Completed
51 enrolled 5 charts
Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS).
Phase 2 Completed
95 enrolled 7 charts